Oragenics Inc. (OGEN.NYSE) announced today that it has entered into a licensing agreement with the National Research Council of Canada (NRC). “With respect to our potential future competitive positioning…
Robertson
Iterum Therapeutics (ITRM.Q) announced today that it has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for its New Drug Application (NDA). Iterum…
Tyme Technologies (TYME.Q) announced today that the United States Patent and Trademark Office has granted the Company additional patent claims related to the Company’s metabolomic technology platform. …
Acorda Therapeutics (ACOR.Q) announced today that it has entered into a distribution and supply agreement with Esteve Pharmaceuticals to commercialize INBRIJA® 33 mg in Spain. “We are…
Schwazze (OTCQX:SHWZ), formerly known as Medicine Man Technologies, announced today that it has closed the transaction to acquire the assets of Southern Colorado Growers (SCG) in Huerfano County, Colorado. The…
Neptune Wellness Solutions (NEPT.T) announced today that it has launched its Forest Remedies’ plant-based Multi Omega 3-6-9 gummies and soft gels. “Forest Remedies’ new multi-omega gummies and soft gels, made…
BioVaxys Technology (BIOV.C) announced today that the US Food and Drug Administration (FDA) has provided its official Written Response to the Company’s request for a Pre-IND Type B review…
Aprea Therapeutics (APRE.Q) today announced positive results from its Phase 2 trial evaluating eprenetapopt with azacitidine for post-transplant maintenance therapy in patients with TP53 mutant MDS and AML. “The…
Lexaria Bioscience (LEXX.Q) announced today that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results. The VIRAL-A20-3 study was performed using Sprague-Dawley rats, with…
MediWound (MDWD.Q), a biopharmaceutical company focused on developing solutions for tissue repair and regeneration, today announced positive topline results from its pivotal phase 3 pediatric clinical study (CIDS – Children…